awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37022497-70D2DBD7-2BBC-48F4-B248-0F01CC6EEE94
Q37022497-70D2DBD7-2BBC-48F4-B248-0F01CC6EEE94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022497-70D2DBD7-2BBC-48F4-B248-0F01CC6EEE94
Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
P2860
Q37022497-70D2DBD7-2BBC-48F4-B248-0F01CC6EEE94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022497-70D2DBD7-2BBC-48F4-B248-0F01CC6EEE94
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc3e2561cc8cedf447af64c55b0937553b1e49ef
P2860
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer